Jubilant Pharmova Limited (NSE:JUBLPHARMA)
India · Delayed Price · Currency is INR 1,112.00
+32.60 (3.02%)
Oct 1, 2025, 3:30 PM IST
Jubilant Pharmova Market Cap
Jubilant Pharmova has a market cap or net worth of 176.35 billion as of October 2, 2025. Its market cap has decreased by -6.71% in one year.
Market Cap
176.35B
Enterprise Value
192.61B
Revenue
74.04B
Ranking
n/a
PE Ratio
38.32
Stock Price
1,112.00
Market Cap Chart
Since May 30, 2000, Jubilant Pharmova's market cap has increased from 406.73M to 176.35B, an increase of 43,258.15%. That is a compound annual growth rate of 27.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2025 | 176.35B | 0.82% |
| Dec 31, 2024 | 174.91B | 101.48% |
| Dec 29, 2023 | 86.81B | 45.28% |
| Dec 30, 2022 | 59.75B | -36.05% |
| Dec 31, 2021 | 93.44B | -30.56% |
| Dec 31, 2020 | 134.55B | 57.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,813.26B |
| Divi's Laboratories | 1,512.51B |
| Cipla | 1,201.94B |
| Apollo Hospitals Enterprise | 1,070.33B |
| Mankind Pharma | 1,016.21B |
| Zydus Lifesciences | 998.28B |
| Fortis Healthcare | 732.88B |
| Alkem Laboratories | 646.73B |